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Abstract This study describes the impact of undiagnosed
and diagnosed asthma on quality of life in schoolchildren
aged 7–10 years and their caregivers in a cross-sectional
community-based study. Diagnosed asthma was defined as
the parents’ confirmation of a physician’s diagnosis of
asthma. Undiagnosed asthma was defined by asthma
symptoms combined with airway reversibility or bronchial
hyperresponsiveness. Quality of life was evaluated in all
children with asthma and a sample of healthy controls by
the Pediatric Asthma Quality of Life Questionnaire, and by
the Paediatric Asthma Caregiver’s Quality of Life Ques-
tionnaire. We studied the impact of breathing problems on
school absence. Compared with healthy controls, quality of
life scores among children and their caregivers were lower
if the child had asthma (P<0.05), with lowest scores in
diagnosed asthma (P<0.05 compared with undiagnosed
asthma). Children with asthma reported more school
absence (P<0.05), with highest absence rate in those with
diagnosed asthma. In conclusion, both undiagnosed and
diagnosed asthma have a significant impact on the quality
of life of both children and their caregivers.







PAQLQ Pediatric Asthma Quality of Life Questionnaire
PACQLQ Paediatric Asthma Caregiver’s Quality of Life
Questionnaire
FEV1 forced expiratory volume in 1 s
Introduction
In Western European and affluent countries, asthma is the
most common chronic disease, with prevalence rates of up to
32% [1]. Since 1980 numerous studies have shown that
asthma in children is underdiagnosed and subsequently
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undertreated [3, 6, 9, 17, 21, 23]. Recent data show that
underdiagnosis is still a problem [8]. Chew et al. [5] reported
that 49% of all children with asthma-like symptoms had not
been diagnosed with asthma and Joseph et al. [10] reported a
prevalence of undiagnosed asthma of 11.7%.
Information about the quality of life in children with
mild to moderate asthma is scarce. The AIRE (Asthma
Insight and Reality) study showed only partial effectiveness
of asthma care in daily life [20]. Only 5.8 % of children met
all criteria for asthma control and over one third of children
had daytime symptoms at least once a week despite
adequate treatment. For undiagnosed asthma, Yeatts et al.
[24] concluded that undiagnosed frequent wheezers report
more sleep disturbances, school absence and activity
limitations than diagnosed asthmatics; however, their study
lacked objective measures to diagnose asthma.
The present study describes the impact of having asthma
on daily life in a community-based population of school-
children with or without a physician’s diagnosis of asthma.
For this we evaluated the quality of life both in children and
their caregivers, as well as the occurrence of asthma
symptoms and their effect on school absence.
Materials and methods
Population and study protocol
The study was conducted in 41 out of 44 primary schools in
four cities in the south of the Netherlands. We asked all
children aged 7–10 years and their parents to participate in
our study. All participating parents completed a question-
naire on respiratory symptoms, demographic and household
characteristics. All participating children were invited for
lung function testing with assessment of reversibility to
salbutamol. Children with asthma symptoms in the past
12 months or reversible airway obstruction were invited for
bronchial challenge with hypertonic saline. Based upon
results from questionnaires, airway reversibility and bron-
chial hyperresponsiveness (BHR) children were identified
as ‘diagnosed asthma’ (DA), ‘undiagnosed asthma’ (UDA),
‘healthy controls’ (HC), ‘asymptomatic airway reversibili-
ty’, or ‘asthma symptoms only. Quality of life was assessed
in all children with asthma (diagnosed and undiagnosed)
and a sample of healthy controls that were randomly
selected from the same class as children with asthma.
Parents received a letter with the results of the symptom
questionnaire and lung function 2 weeks after finishing the
study protocol.
Approval for the study was obtained from the central
Committee on Research involving Human Subjects
(CCMO) in the Hague, the Netherlands. Informed written
consent was obtained from the parents of all children.
Questionnaire
Parents completed a questionnaire that included the ISAAC
core questions on symptoms of asthma, rhinitis and eczema
[2]. Additional data were collected on household character-
istics. Asthma symptoms were defined as wheeze or a dry
cough at night in the past 12 months.
Spirometry and reversibility
Maximal flow-volume curves were measured using a
hand-held spirometer (Vitalograph, Buckingham, UK)
according to the ERS guidelines [18]. A minimum of
two technically acceptable baseline flow-volume curves
were performed and the highest of two reproducible (within
5%) measurements of forced expiratory volume in 1 s
(FEV1) was recorded as baseline FEV1. Subsequently,
800 µg of salbutamol was administered via a metered dose
inhaler using a volumatic spacer (GSK, Uxbridge, UK).
Airway reversibility was defined as an increase of FEV1 of
≥10% of the predicted value 10 min after administration of
salbutamol.
Hypertonic saline testing
Bronchial hyperresponsiveness was assessed by inhalation
challenge with nebulized hypertonic (4.5%) saline using an
ultrasound nebulizer (Klava 2000/4000, Klava Eltromed,
Bielefeld, Germany) according to the ISAAC protocol.
BHR was assessed on a different day than the spirometry
[22]. All children were asked to withhold all asthma
medications for at least 12 h beforehand. Children with a
baseline FEV1 ≤75% were excluded. The children inhaled
the saline for periods of increasing duration: 0.5, 1, 2, 4,
and 8 min. FEV1 was measured 1 min after each inhalation
period and the next inhalation period started after 3 min.
Bronchial challenge was stopped if FEV1 had fallen at least
15% from baseline or if the total inhalation period of
15.5 min had been completed. A child was defined as
having BHR if FEV1 had dropped by ≥15% from baseline
during the inhalation challenge.
Daily impact of asthma
Quality of life was measured with the Pediatric Asthma
Quality of Life Questionnaire (PAQLQ) for children, and
with the Pediatric Asthma Caregiver’s Quality of Life
Questionnaire (PACQLQ) for their caregivers [11, 12]. For
both questionnaires scores range from 1 to 7, with 7
indicative of maximal quality of life. The PAQLQ consists
of three domains, i.e. emotions, activity and symptoms. The
PACQLQ consists of two domains, i.e. the emotions
domain and activity domain.
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School absence because of respiratory disease was evalu-
ated by the question: “How often was your child absent from
school due to breathing problems in the last 12 months?”
Additionally, children completed a 5-day diary addressing the
following question: “Did you feel different or left out today
because of shortness of breath, coughing or wheezing?”
Definitions
A child was considered having diagnosed asthma if the
parents confirmed that their child had physician-diagnosed
asthma in the last 12 months. A child was considered having
undiagnosed asthma if the child had (1) no physician-
diagnosed asthma in the last 12 months, (2) asthma symptoms
(wheeze or dry cough) in the last 12months, and (3) either had
reversible airway obstruction or BHR. Healthy controls (HC)
had no asthma diagnosis or symptoms in the last 12 months,
and no reversible airway obstruction. The remainder children
comprised those with asymptomatic airway reversibility
(airway reversibility without asthma diagnosis or symptoms),
and children with asthma symptoms only.
Data analysis
All data of the questionnaires were double-entered into the
database using Microsoft Access software. Chi-square tests
and ANOVA with a Bonferroni post-hoc test were used to
analyse differences between the groups. Data were analysed
using the statistical package SPSS version 11.0.
Results
Participants
Of 44 eligible schools, 41 participated in the study. Reasons
for non-participation were recent involvement in another
study (n=2) and school policy never to participate in
medical studies (n=1). We invited 2,745 children and their
parents to participate in the study in the period September
2002 to April 2005, of which 1758 (64%) gave informed
consent to participate. We excluded 144 children from
further analysis; reasons for excluding were missing
questionnaire data (n=60), refusal to participate in bron-
chial challenge testing (n=31), not completing the bronchi-
al challenge test due to nausea or coughing (n=3) or
inability to meet technical conditions (n=50).
Diagnosis and demographics
The final study population comprised 1,614 children, of
whom 81 (5.0%) had diagnosed asthma and 130 (8%)
undiagnosed asthma according to our criteria. Asymptom-
atic airway reversibility occurred in 14% and 19% had
asthma symptoms only. Of the remaining healthy controls,
we randomly selected 202 children for assessment of
quality of life. Table 1 presents the characteristics of the
study population. Children with diagnosed asthma more
frequently had a father with asthma compared with the
children with undiagnosed asthma (P<0.05) and healthy
controls, whereas having a mother with asthma occurred
more frequently in children with both diagnosed and
undiagnosed asthma (P<0.001).
Table 2 presents clinical characteristics of the patient
groups. Wheeze in the last 12 months occurred most
frequently in diagnosed asthma (86%) compared with
undiagnosed asthma (56%) and healthy controls (0%)
(P<0.001 for all comparisons). In contrast, children with
undiagnosed asthma had the lowest baseline FEV1, which
showed the greatest increase after inhalation of salbutamol
(9%, 5%, 2%, respectively; UDA vs HC; P<0.001, UDA vs
DA; P=0.07). Furthermore airway reversibility and BHR
occurred more frequently in children with undiagnosed
asthma than in children with diagnosed asthma and healthy
controls (reversibility 52%, 24% and 0% for, respectively,
UDA, DA and HC, P<0.001; respectively, 73%, 47%, and
11% for BHR, P<0.001).









Male 73 (56) 47 (58) 100 (50)
Female 57 (44) 34 (42) 102 (50)
Mean age±SD (years) 9.4±0.7 9.4±0,8 9.4±0.7
Mother asthma
ever, n (%)
19 (17) 16 (23) 4 (2)
Father asthma
ever, n (%)
7 (5) 11 (16) 12 (7)
Mother current
smoker, n (%)
26 (20) 10 (14) 41 (22)
Father current
smoker, n (%)
30 (26) 17 (24) 42 (22)
Mother’s education
Low, n (%) 17 (15) 14 (20) 33 (17)
Moderate, n (%) 56 (49) 34 (48) 95 (50)
High, n (%) 41 (36) 23 (32) 62 (33)
Father’s education
Low, n (%) 20 (20) 16 (24) 37 (20)
Moderate, n (%) 41 (40) 22 (32) 65 (35)
High, n (%) 40 (40) 30 (44) 82 (45)
Pet ownership
Currently, n (%) 78 (70) 39 (54) 117 (61)
Ever, n (%) 89 (80) 55 (76) 142 (74)
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Impact on daily life
Table 3 presents data on the quality of life of children and
their caregivers. For all domains, children with diagnosed
or undiagnosed asthma had lower quality of life scores than
healthy controls (P<0.05). Quality of life in children with
diagnosed asthma was lower than in children with
undiagnosed asthma for all domains (P<0.05). Quality of
life scores in caregivers showed a similar pattern. Irrespec-
tive whether diagnosed or not, asthmatic children showed a
lower score on the activity domain than their caregivers did
(P<0.05).
We estimated the effect on daily function by a 5-days’
symptom diary and evaluation of school absence in the last
12 months. Children with diagnosed asthma reported twice
as many symptoms in the diary than children with
undiagnosed asthma (11% and 5%, respectively, P<0.05).
Children with diagnosed and undiagnosed asthma were
more than 1 week absent from school in the last 12 months
due to respiratory symptoms than healthy controls, i.e.
31%, 17%, and 0%, respectively (P<0.001) (Table 4).
Because corticosteroid treatment may affect lung function
and quality of life score, we repeated the analysis after
excluding children with undiagnosed asthma that used
inhaled corticosteroids. Results remained essentially the
same.
Discussion
In the present study, we found a lower quality of life on all
domains in children with diagnosed and undiagnosed
asthma compared with healthy children. We found the
same results for their caregivers. Lowest scores were
observed in children with diagnosed asthma. Similarly,
symptoms during five consecutive days and school absence
in the last 12 months occurred more frequently in asthmatic
children, with the highest impact in children with diagnosed
asthma.
Table 3 Quality of life mean score of children and caregivers with undiagnosed asthma, diagnosed asthma and healthy controls
Quality of life score of children Undiagnosed asthma Diagnosed asthma Healthy controls P value
n Mean (95% C.I.) n Mean (95% C.I.) n Mean (95% C.I.)
Emotions domain 103 6.6 (6.4–6.8) 67 6.4 (6.1–6.6) 153 7.0 (6.9–7) <0.05a, b, c
Activity domain 90 5.6 (5.3–5.9) 54 5.1 (4.8–5.4) 93 6.9 (6.8–7) <0.05a, b, c
Symptom domain 91 6.2 (6.0–6.4) 55 5.6 (5.3–5.9) 122 6.9 (6.9–7) <0.001a, b, c
Combined domain 77 6.1 (5.8–6.3) 47 5.6 (5.4–5.9) 90 7.0 (6.9–7) <0.05a, b, c
Quality of life score of caregivers
Emotions domain 103 6.7 (6.6–6.8) 69 6.2 (5.9–6.4) 165 7.0 (6.9–7) <0.001a, b, c
Activity domain 111 6.7 (6.6–6.8) 72 6.4 (6.2–6.6) 168 7.0 (6.9–7) <0.05a, b, c
Combined domain 102 6.7 (6.6–6.8) 68 6.3 (6.1–6.5) 165 7.0 (6.9–7) <0.001a, b, c
a Significant difference between undiagnosed asthma and diagnosed asthma
b Significant difference between undiagnosed asthma and healthy controls
c Significant difference between diagnosed asthma and healthy controls
Table 2 Clinical characteristics of the patient groups
Undiagnosed asthma Diagnosed asthma Healthy controls P value
Symptoms in last 12 months
Wheeze, n (%) 72 (56) 70 (86) 0 (0) <0.001a, b, c
Dry cough at night, n (%) 90 (71) 54 (70) 0 (0) <0.001b, c
Lung function parameters
Mean baseline FEV1 % predicted 94 98 100 <0.001
b
Mean baseline FVC % predicted 89 95 95 <0.05a, b
Change in FEV1 after BD (%) +9 +5 +2 <0.001
b
Reversibility ≥10%, n (%) 67 (52) 19 (24) 0 (0) <0.001a, b, c
BHR, n (%) 93 (73) 38 (47) 21 (11) <0.001a, b, c
Inhaled corticosteroids 12 (9%) 60 (74%) 0 (0)
a Significant difference between undiagnosed asthma and diagnosed asthma
b Significant difference between undiagnosed asthma and healthy controls
c Significant difference between diagnosed asthma and healthy controls
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The major strength of our study is that, to our
knowledge, this is the first population-based study which
evaluated quality of life with standardized disease-specific
questionnaires in children with undiagnosed asthma and
diagnosed asthma and their caregivers and compared these
children with healthy controls.
We found a higher frequency of BHR and a lower
prevalence of wheeze in children with undiagnosed asthma
than children with diagnosed asthma. There are several
explanations for this finding. First, bronchial hyperrespon-
siveness was used in the definition of undiagnosed asthma,
whereas bronchial hyperresponsiveness was not required in
the definition of diagnosed asthma. Another explanation
might be the dependence on recall of asthma symptoms.
Recall by parents can be faulty. Furthermore, parents may
not witness every asthma symptom a child experiences,
which might explain that night-time symptoms are equal in
children with undiagnosed asthma and diagnosed asthma.
Nonetheless, patient report of asthma symptoms has long
been a key factor in physician’s decision making, and the
survey mimics the questions they pose as part of assess-
ment. Responses to the questionnaire are equally reliable as
similar questions in the physician’s office.
Our results on quality of life with the lowest score in
diagnosed asthma suggest that children with undiagnosed
asthma have a milder degree of asthma than children with
diagnosed asthma. This is in agreement with quality of life
scores reported by others. For example, our children with
diagnosed asthma had quality of life scores similar to those
in children with moderate asthma, and our scores for
undiagnosed asthma were comparable with those in children
with mild asthma as reported by Raat et al. [19] The
relevance of mild asthma should not be underestimated.
Fawcett et al. [7] showed that life-threatening exacerbations
regularly occur in mild asthma. Moreover, mild asthma
accounts for the majority of pediatric admissions.
The clinical interpretation of differences in quality of life
is difficult because experience in their use is still limited.
Juniper et al. [13] proposed a difference of 0.5 or higher as
being clinically relevant for the PAQLQ. Knorr et al. [15]
studied the effect of treatment in 6- to 14-year-old asthmatic
children and observed a significant improvement of both
FEV1 and quality of life scores (with 0.4 for the emotional
domain and 0.5 for the activity domain). In the light of
these studies, our results suggest a clinically relevant
impairment of quality of life in asthmatic children,
irrespective of whether diagnosed or not. Until now, no
reports are available on the clinical relevance of the parental
scores of quality of life.
Our observations of lowest quality of life and highest
symptom impact in diagnosed asthma compared with
undiagnosed asthma seem in contradiction with observa-
tions on markers of airway obstruction (FEV1, reversibility,
BHR), which was highest in undiagnosed asthma.
Juniper et al. [14] reported a similar discrepancy. It is
probable that clinical measures of airway status (such as
airway calibre and markers of inflammation) evaluate a
different component of asthma health status than quality of
life. For instance, lung function is a static indicator in a
variable disease, whereas quality of life scores reflect the
patient’s perceptions of the condition over a longer period
of time. In addition, the stigma of being labelled as having
asthma can be an explanation for the lower quality of life
scores in children with diagnosed asthma. Further studies
are needed to evaluate the effect of being diagnosed and
medical treatment on quality of life in a community sample
of undiagnosed asthma.
The following points may have affected our study
results. First, we did not collect information on the reasons
for non-response or the extent to which this may have
biased our results. Second, bias may have been introduced
if parents interpreted symptom questions different than the
questionnaire definition [4, 16, 25]. Additionally, recall bias
cannot be excluded since questions referred to a period of
the past 12 months. For symptoms, we attempted to
minimize bias by using the validated ISAAC questionnaire.
One might argue that asthma-specific quality of life
questionnaires are inappropriate to be used in healthy
controls or in subjects without a diagnosis of asthma.
However, the PAQLQ and PACQLQ also include questions
on the impact of respiratory symptoms without making
reference to ‘asthma’. Therefore, we have considered them
appropriate to use in children with undiagnosed asthma and
healthy controls. Our observations of the highest scores in
healthy controls that approximated the maximum value
may be considered a confirmation. Furthermore, the
disease-specific quality of life was significantly impaired
in subjects who could be expected to experience impair-
ments: the children with undiagnosed asthma. In addition,
the results of more school absence in children with
undiagnosed asthma compared with healthy controls sup-
ports the results of lower quality of life scores in children
with undiagnosed asthma. A last comment addresses the
selection of our patient groups. In this study, children with
“asymptomatic airway reversibility” or “asthma symptoms







Never 56 (50) 28 (40) 179 (93) a
<1 week 37 (33) 20 (29) 13 (7) a
1–2 weeks 12 (11) 21 (30) 0 a
3–4 weeks 5 (4) 1 (1) 0 a
>4 weeks 2 (2) 0 0 a
aP value <0.001
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only” were excluded, because we aimed at a highest
discrimination between asthma and healthy controls. There-
fore, we included objective parameters (airway reversibility
and BHR) for the definition of undiagnosed asthma.
Nevertheless misclassification may have occurred since
airway reversibility is variable present in asthma.
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